These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
DELAWARE
|
|
95-4405754
|
|
|
|
(State or other jurisdiction of
incorporation or organization)
|
|
(I.R.S. Employer
Identification No.)
|
|
|
Large accelerated filer
o
|
|
Accelerated filer
x
|
|
|
Non-accelerated filer
o
(Do not check if a smaller reporting company)
|
|
Smaller reporting company
o
|
|
|
ACACIA RESEARCH CORPORATION
|
|||
|
Table Of Contents
|
|||
|
|
|
|
|
|
Part I.
|
Financial Information
|
|
|
|
|
|
|
|
|
|
Item 1.
|
||
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
Item 2.
|
||
|
|
|
|
|
|
|
Item 3.
|
||
|
|
|
|
|
|
|
Item 4.
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Part II.
|
|||
|
|
|
|
|
|
|
Item 6.
|
||
|
|
|
|
|
|
|
|
|
|
|
Signatures
|
|
||
|
|
|
|
|
|
Exhibit Index
|
|
||
|
|
September 30,
2010 |
|
December 31,
2009 |
||||
|
ASSETS
|
|
|
|
||||
|
|
|
|
|
||||
|
Current assets:
|
|
|
|
||||
|
Cash and cash equivalents
|
$
|
83,426
|
|
|
$
|
51,735
|
|
|
Accounts receivable
|
38,980
|
|
|
5,110
|
|
||
|
Prepaid expenses and other current assets
|
1,779
|
|
|
1,081
|
|
||
|
Total current assets
|
124,185
|
|
|
57,926
|
|
||
|
|
|
|
|
||||
|
Property and equipment, net of accumulated depreciation
|
136
|
|
|
163
|
|
||
|
Patents, net of accumulated amortization
|
15,242
|
|
|
17,510
|
|
||
|
Investments - noncurrent
|
2,152
|
|
|
2,152
|
|
||
|
Other assets
|
514
|
|
|
505
|
|
||
|
|
$
|
142,229
|
|
|
$
|
78,256
|
|
|
|
|
|
|
||||
|
LIABILITIES AND STOCKHOLDERS' EQUITY
|
|
|
|
||||
|
|
|
|
|
||||
|
Current liabilities:
|
|
|
|
||||
|
Accounts payable and accrued expenses
|
$
|
8,367
|
|
|
$
|
8,006
|
|
|
Royalties and contingent legal fees payable
|
24,862
|
|
|
12,402
|
|
||
|
Deferred revenues
|
—
|
|
|
1,510
|
|
||
|
Total current liabilities
|
33,229
|
|
|
21,918
|
|
||
|
|
|
|
|
||||
|
Other liabilities
|
290
|
|
|
369
|
|
||
|
Total liabilities
|
33,519
|
|
|
22,287
|
|
||
|
|
|
|
|
||||
|
Commitments and contingencies (Note 5)
|
|
|
|
||||
|
|
|
|
|
||||
|
Stockholders' equity:
|
|
|
|
||||
|
Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; no shares issued or outstanding
|
—
|
|
|
—
|
|
||
|
Common stock, par value $0.001 per share; 100,000,000 shares authorized; 34,762,019 and 31,912,066 shares issued and outstanding as of September 30, 2010 and December 31, 2009, respectively
|
35
|
|
|
32
|
|
||
|
Additional paid-in capital
|
186,044
|
|
|
173,672
|
|
||
|
Accumulated deficit
|
(80,921
|
)
|
|
(120,242
|
)
|
||
|
Total Acacia Research Corporation stockholders' equity
|
105,158
|
|
|
53,462
|
|
||
|
|
|
|
|
||||
|
Noncontrolling interests in operating subsidiaries
|
3,552
|
|
|
2,507
|
|
||
|
|
|
|
|
||||
|
Total stockholders' equity
|
108,710
|
|
|
55,969
|
|
||
|
|
$
|
142,229
|
|
|
$
|
78,256
|
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
|
September 30,
2010 |
|
September 30,
2009 |
|
September 30,
2010 |
|
September 30,
2009 |
||||||||
|
|
|
|
|
|
|
|
|
||||||||
|
Revenues
|
$
|
63,949
|
|
|
$
|
16,169
|
|
|
$
|
118,727
|
|
|
$
|
47,482
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Operating costs and expenses:
|
|
|
|
|
|
|
|
||||||||
|
Cost of revenues:
|
|
|
|
|
|
|
|
||||||||
|
Inventor royalties
|
14,508
|
|
|
4,673
|
|
|
21,296
|
|
|
12,069
|
|
||||
|
Contingent legal fees
|
9,739
|
|
|
3,799
|
|
|
17,611
|
|
|
10,521
|
|
||||
|
Litigation and licensing expenses - patents
|
2,890
|
|
|
3,957
|
|
|
11,019
|
|
|
8,418
|
|
||||
|
Amortization of patents
|
1,963
|
|
|
1,245
|
|
|
5,542
|
|
|
3,370
|
|
||||
|
Marketing, general and administrative expenses (including non-cash stock compensation expense of $1,615 and $5,574 for the three and nine months ended September 30, 2010, respectively and $1,472 and $5,573 for the three and nine months ended September 30, 2009, respectively)
|
6,353
|
|
|
4,709
|
|
|
18,741
|
|
|
15,835
|
|
||||
|
Research, consulting and other expenses - business development
|
461
|
|
|
363
|
|
|
1,286
|
|
|
1,173
|
|
||||
|
Total operating costs and expenses
|
35,914
|
|
|
18,746
|
|
|
75,495
|
|
|
51,386
|
|
||||
|
Operating income (loss)
|
28,035
|
|
|
(2,577
|
)
|
|
43,232
|
|
|
(3,904
|
)
|
||||
|
|
|
|
|
|
|
|
|
||||||||
|
Other income:
|
|
|
|
|
|
|
|
||||||||
|
Interest income
|
44
|
|
|
23
|
|
|
83
|
|
|
122
|
|
||||
|
Gain on foreign currency translation
|
—
|
|
|
—
|
|
|
—
|
|
|
201
|
|
||||
|
Gain on investments
|
—
|
|
|
201
|
|
|
—
|
|
|
235
|
|
||||
|
Total other income
|
44
|
|
|
224
|
|
|
83
|
|
|
558
|
|
||||
|
|
|
|
|
|
|
|
|
||||||||
|
Income (loss) from operations before provision for income taxes
|
28,079
|
|
|
(2,353
|
)
|
|
43,315
|
|
|
(3,346
|
)
|
||||
|
Provision for income taxes
|
(297
|
)
|
|
(47
|
)
|
|
(605
|
)
|
|
(124
|
)
|
||||
|
Net income (loss) including noncontrolling interests in operating subsidiaries
|
27,782
|
|
|
(2,400
|
)
|
|
42,710
|
|
|
(3,470
|
)
|
||||
|
Net income attributable to noncontrolling interests in operating subsidiaries
|
(3,107
|
)
|
|
(1,029
|
)
|
|
(3,389
|
)
|
|
(3,150
|
)
|
||||
|
Net income (loss) attributable to Acacia Research Corporation
|
$
|
24,675
|
|
|
$
|
(3,429
|
)
|
|
$
|
39,321
|
|
|
$
|
(6,620
|
)
|
|
|
|
|
|
|
|
|
|
||||||||
|
Net income (loss) per common share attributable to
Acacia Research Corporation:
|
|
|
|
|
|
|
|
||||||||
|
Basic income (loss) per share
|
$
|
0.75
|
|
|
$
|
(0.11
|
)
|
|
$
|
1.24
|
|
|
$
|
(0.22
|
)
|
|
Diluted income (loss) per share
|
$
|
0.70
|
|
|
$
|
(0.11
|
)
|
|
$
|
1.14
|
|
|
$
|
(0.22
|
)
|
|
Weighted average number of shares outstanding, basic
|
32,794,553
|
|
|
30,071,492
|
|
|
31,776,074
|
|
|
29,818,956
|
|
||||
|
Weighted average number of shares outstanding, diluted
|
35,105,353
|
|
|
30,071,492
|
|
|
34,448,666
|
|
|
29,818,956
|
|
||||
|
|
Nine Months Ended
|
||||||
|
|
September 30,
2010 |
|
September 30,
2009 |
||||
|
Cash flows from operating activities:
|
|
|
|
||||
|
Net income (loss) including noncontrolling interests in operating subsidiaries
|
$
|
42,710
|
|
|
$
|
(3,470
|
)
|
|
Adjustments to reconcile net income (loss) including noncontrolling interests in operating subsidiaries to net cash provided by operating activities:
|
|
|
|
||||
|
Depreciation and amortization
|
5,608
|
|
|
3,465
|
|
||
|
Non-cash stock compensation
|
5,574
|
|
|
5,573
|
|
||
|
Gain on investments
|
—
|
|
|
(235
|
)
|
||
|
Changes in assets and liabilities:
|
|
|
|
||||
|
Accounts receivable
|
(33,870
|
)
|
|
901
|
|
||
|
Prepaid expenses and other assets
|
(707
|
)
|
|
(4,378
|
)
|
||
|
Accounts payable and accrued expenses
|
82
|
|
|
2,574
|
|
||
|
Royalties and contingent legal fees payable
|
12,460
|
|
|
1,774
|
|
||
|
Deferred revenues
|
(1,510
|
)
|
|
(308
|
)
|
||
|
|
|
|
|
||||
|
Net cash provided by operating activities
|
30,347
|
|
|
5,896
|
|
||
|
|
|
|
|
||||
|
Cash flows from investing activities:
|
|
|
|
||||
|
Purchase of property and equipment
|
(39
|
)
|
|
(60
|
)
|
||
|
Sale of available-for-sale investments
|
—
|
|
|
990
|
|
||
|
Patent acquisition costs
|
(3,074
|
)
|
|
(9,162
|
)
|
||
|
|
|
|
|
||||
|
Net cash used in investing activities
|
(3,113
|
)
|
|
(8,232
|
)
|
||
|
|
|
|
|
||||
|
Cash flows from financing activities:
|
|
|
|
||||
|
Distributions to noncontrolling interests in operating subsidiary
|
(2,788
|
)
|
|
(2,121
|
)
|
||
|
Contributions from noncontrolling interests in operating subsidiary
|
444
|
|
|
—
|
|
||
|
Repurchased restricted common stock
|
—
|
|
|
(1,107
|
)
|
||
|
Proceeds from the exercise of stock options
|
6,801
|
|
|
85
|
|
||
|
|
|
|
|
||||
|
Net cash provided by (used in) financing activities
|
4,457
|
|
|
(3,143
|
)
|
||
|
|
|
|
|
||||
|
Increase (decrease) in cash and cash equivalents
|
31,691
|
|
|
(5,479
|
)
|
||
|
|
|
|
|
||||
|
Cash and cash equivalents, beginning
|
51,735
|
|
|
48,279
|
|
||
|
|
|
|
|
||||
|
Cash and cash equivalents, ending
|
$
|
83,426
|
|
|
$
|
42,800
|
|
|
|
Three Months Ended September 30,
|
|
Nine Months Ended September 30,
|
||||||||||||||||||||
|
|
2009
|
|
2009
|
||||||||||||||||||||
|
|
As Reported
|
|
As Adjusted
|
|
Effect of Change
|
|
As Reported
|
|
As Adjusted
|
|
Effect of Change
|
||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Revenues
|
$
|
12,831
|
|
|
$
|
16,169
|
|
|
$
|
3,338
|
|
|
$
|
40,512
|
|
|
$
|
47,482
|
|
|
$
|
6,970
|
|
|
Inventor royalties
|
3,010
|
|
|
4,673
|
|
|
1,663
|
|
|
8,890
|
|
|
12,069
|
|
|
3,179
|
|
||||||
|
Contingent legal fees
|
3,470
|
|
|
3,799
|
|
|
329
|
|
|
9,890
|
|
|
10,521
|
|
|
631
|
|
||||||
|
Operating loss
|
(3,923
|
)
|
|
(2,577
|
)
|
|
1,346
|
|
|
(7,064
|
)
|
|
(3,904
|
)
|
|
3,160
|
|
||||||
|
Net loss attributable to Acacia Research Corporation
|
(4,775
|
)
|
|
(3,429
|
)
|
|
1,346
|
|
|
(9,780
|
)
|
|
(6,620
|
)
|
|
3,160
|
|
||||||
|
Basic and diluted loss per share
|
(0.16
|
)
|
|
(0.11
|
)
|
|
0.04
|
|
|
(0.33
|
)
|
|
(0.22
|
)
|
|
0.11
|
|
||||||
|
•
|
Level 1 - Observable Inputs: Quoted prices in active markets for identical investments;
|
|
•
|
Level 2 - Pricing Models with Significant Observable Inputs: Other significant observable inputs, including quoted prices for similar investments, interest rates, credit risk, etc.; and
|
|
•
|
Level 3 - Unobservable Inputs: Significant unobservable inputs, including the entity's own assumptions in determining the fair value of investments.
|
|
|
Three Months Ended September 30,
|
|
Nine Months Ended September 30,
|
||||||||
|
|
January 1, 2010
|
|
January 1, 2009
|
|
January 1, 2010
|
|
January 1, 2009
|
||||
|
|
|
|
|
|
|
|
|
||||
|
Weighted-average common shares outstanding - basic
|
32,794,553
|
|
|
30,071,492
|
|
|
31,776,074
|
|
|
29,818,956
|
|
|
Dilutive effect of Equity-based Incentive Awards
|
2,310,800
|
|
|
—
|
|
|
2,672,592
|
|
|
—
|
|
|
Weighted-average common shares outstanding - diluted
|
35,105,353
|
|
|
30,071,492
|
|
|
34,448,666
|
|
|
29,818,956
|
|
|
|
|
|
|
|
|
|
|
||||
|
Equity-based Incentive Awards excluded from the computation of diluted income (loss) per share because the effect of inclusion would have been anti-dilutive
|
64,768
|
|
|
5,341,165
|
|
|
250,336
|
|
|
5,341,165
|
|
|
|
Three Months Ended September 30,
|
|
Nine Months Ended September 30,
|
||||||||||||
|
|
2010
|
|
2009
|
|
2010
|
|
2009
|
||||||||
|
|
|
|
|
|
|
|
|
||||||||
|
Balance as of July 1 and January 1, respectively
|
$
|
2,152
|
|
|
$
|
3,123
|
|
|
$
|
2,152
|
|
|
$
|
3,239
|
|
|
Total gains (realized or unrealized):
|
|
|
|
|
|
|
|
||||||||
|
Recognized gains included in earnings
(1)
|
—
|
|
|
201
|
|
|
—
|
|
|
235
|
|
||||
|
Settlements
|
—
|
|
|
(840
|
)
|
|
—
|
|
|
(990
|
)
|
||||
|
Balance as of September 30
|
$
|
2,152
|
|
|
$
|
2,484
|
|
|
$
|
2,152
|
|
|
$
|
2,484
|
|
|
|
Three Months Ended September 30,
|
|
Nine Months Ended September 30,
|
||||||||||||
|
|
2010
|
|
2009
|
|
2010
|
|
2009
|
||||||||
|
|
|
|
|
|
|
|
|
||||||||
|
Revenues (in thousands)
|
$
|
63,949
|
|
|
$
|
16,169
|
|
|
$
|
118,727
|
|
|
$
|
47,482
|
|
|
New agreements executed
|
51
|
|
|
36
|
|
|
180
|
|
|
85
|
|
||||
|
Licensing and enforcement programs generating revenues
|
36
|
|
|
18
|
|
|
52
|
|
|
25
|
|
||||
|
Licensing and enforcement programs with initial revenues
|
12
|
|
|
3
|
|
|
27
|
|
|
8
|
|
||||
|
New patent portfolios
|
4
|
|
|
9
|
|
|
27
|
|
|
22
|
|
||||
|
As of Date:
|
|
Trailing Twelve -Month Revenues
|
|
% Change
|
|||
|
|
|
|
|
|
|||
|
September 30, 2010
|
|
$
|
138,585
|
|
|
53
|
%
|
|
June 30, 2010
|
|
90,805
|
|
|
1
|
%
|
|
|
March 31, 2010
|
|
90,155
|
|
|
34
|
%
|
|
|
December 31, 2009
|
|
67,340
|
|
|
2
|
%
|
|
|
September 30, 2009
|
|
65,749
|
|
|
4
|
%
|
|
|
•
|
Audio Communications Fraud Detection technology
|
|
•
|
|
|
•
|
Authorized Spending Accounts technology
|
|
•
|
Lighting Ballast technology
|
|
•
|
Automatic Image Labeling technology
(1) (2)
|
|
•
|
Location Based Services technology
|
|
•
|
Business Process Modeling (BPM) technology
(1)
|
|
•
|
Medical Image Stabilization technology
|
|
•
|
Camera Support technology
(1) (2)
|
|
•
|
Medical Monitoring technology
(1)
|
|
•
|
Child-friendly Secure Mobile Phones technology
|
|
•
|
Mobile Computer Synchronization technology
(1) (2)
|
|
•
|
Compiler technology
(1)
|
|
•
|
Mutli-Dimensional Database Compression technology
|
|
•
|
Computer Graphics technology
(1) (2)
|
|
•
|
Network Monitoring technology
(1)
|
|
•
|
Credit Card Fraud Protection technology
|
|
•
|
Network Remote Access technology
(1)
|
|
•
|
Database Access technology
|
|
•
|
Online Ad Tracking technology
(1) (2)
|
|
•
|
Database Management technology
|
|
•
|
Online Auction Guarantee technology
|
|
•
|
Digital Signal Processing Architecture technology
(1) (2)
|
|
•
|
Online Newsletters with Links technology
(1)
|
|
•
|
Digital Video Enhancement technology
(1)
|
|
•
|
Online Promotion technology
|
|
•
|
Disk Array Systems & Storage Area Network technology
(1)
|
|
•
|
Picture Archiving & Communications System technology
|
|
•
|
DMT® technology
|
|
•
|
Pop-up Internet Advertising technology
|
|
•
|
Document Generation technology
|
|
•
|
Records Management technology
(1)
|
|
•
|
DRAM Memory Architecture technology
(1) (2)
|
|
•
|
Rule Based Monitoring technology
|
|
•
|
Facilities Operation Management System technology
(1)
|
|
•
|
Short Messaging in Cellular Telephony technology
(1) (2)
|
|
•
|
File Locking In Shared Storage Networks technology
|
|
•
|
Software Installation technology
(1)
|
|
•
|
High Performance Computer Architecture technology
|
|
•
|
Storage technology
|
|
•
|
Image Resolution Enhancement technology
|
|
•
|
Telematics technology
|
|
•
|
Improved Commercial Print technology
(1) (2)
|
|
•
|
Virtual Computer Workspace technology
|
|
•
|
Improved Lighting technology
(1)
|
|
•
|
Virtual Server technology
|
|
•
|
Information Portal Software technology
(1) (2)
|
|
•
|
Visual Data Evaluation technology
(1)
|
|
•
|
Interactive Mapping technology
(1)
|
|
•
|
Website Crawling technology
(1)
|
|
•
|
Internet Radio Advertising technology
|
|
•
|
Wireless Multimedia technology
(1) (2)
|
|
(1)
|
Initial revenues recognized during the nine months ended September 30, 2010.
|
|
(2)
|
Initial revenues recognized during the three months ended September 30, 2010.
|
|
•
|
Audio Communications Fraud Detection technology
|
|
•
|
Microprocessor technology
(1) (2)
|
|
•
|
Audio Video Enhancement & Synchronization technology
|
|
•
|
Online Auction Guarantee technology
|
|
•
|
Child-friendly Secure Mobile Phones technology
(1)
|
|
•
|
Online Promotion technology
(1) (2)
|
|
•
|
Credit Card Fraud Protection technology
|
|
•
|
Picture Archiving & Communications System technology
|
|
•
|
Database Access technology
(1)
|
|
•
|
Pop-up Internet Advertising technology
|
|
•
|
DMT® technology
|
|
•
|
Projector technology
|
|
•
|
eCommerce Pricing technology
|
|
•
|
Remote Management of Imaging Devices technology
|
|
•
|
Encrypted Media & Playback Devices technology
(1)
|
|
•
|
Rule Based Monitoring technology
|
|
•
|
Heated Surgical Blades technology
(1)
|
|
•
|
Storage technology
|
|
•
|
High Quality Image Processing technology
|
|
•
|
Surgical Catheter technology
(1)
|
|
•
|
Lighting Ballast technology
(1) (2)
|
|
•
|
Telematics technology
|
|
•
|
Location Based Services technology
|
|
•
|
Vehicle maintenance technology
|
|
•
|
Medical Image Stabilization technology
|
|
|
|
|
(1)
|
Initial revenues recognized during the nine months ended September 30, 2009.
|
|
(2)
|
Initial revenues recognized during the three months ended September 30, 2009.
|
|
|
Three Months Ended September 30,
|
|
%
|
|
Nine Months Ended September 30,
|
|
%
|
||||||||||||||
|
|
2010
|
|
2009
|
|
Change
|
|
2010
|
|
2009
|
|
Change
|
||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Revenues
|
$
|
63,949
|
|
|
$
|
16,169
|
|
|
296
|
%
|
|
$
|
118,727
|
|
|
$
|
47,482
|
|
|
150
|
%
|
|
Operating costs and expenses
|
35,914
|
|
|
18,746
|
|
|
92
|
%
|
|
75,495
|
|
|
51,386
|
|
|
47
|
%
|
||||
|
Operating income (loss)
|
28,035
|
|
|
(2,577
|
)
|
|
**
|
|
43,232
|
|
|
(3,904
|
)
|
|
**
|
||||||
|
Net income attributable to noncontrolling interests in operating subsidiaries
|
3,107
|
|
|
1,029
|
|
|
202
|
%
|
|
3,389
|
|
|
3,150
|
|
|
8
|
%
|
||||
|
Net income (loss) attributable to Acacia Research Corporation
|
24,675
|
|
|
(3,429
|
)
|
|
**
|
|
39,321
|
|
|
(6,620
|
)
|
|
**
|
||||||
|
•
|
Revenues increased by
$47.8 million
, or
296%
, due primarily to an increase in the average revenue per executed agreement.
|
|
•
|
Cost of Revenues and Other Operating Expenses:
|
|
◦
|
Inventor royalties, net income attributable to noncontrolling interests, and contingent legal fees, on a combined basis, increased
188%
, primarily reflecting the increase in related revenues for the three months ended September 30, 2010. The increase was less than the percentage increase in related revenues due to, in the aggregate, lower or no inventor royalty or contingent legal fee arrangement obligations associated with the portfolios generating revenues during the three months ended September 30, 2010, as compared to the prior year period.
|
|
◦
|
Litigation and licensing expenses-patents decreased to
$2.9 million
, as compared to
$4.0 million
,
due to a lower net level of litigation support, third party technical consulting and professional expert expenses incurred during the three months ended September 30, 2010. The decrease was partially offset by an increase in litigation and licensing expenses incurred in connection with our continued investment in ongoing licensing and enforcement programs and new licensing and enforcement programs commenced since the end of the prior year period.
|
|
◦
|
Marketing, general and administrative expenses increased to
$6.4 million
, as compared to
$4.7 million
,
due primarily to an increase in variable performance-based compensation costs, an increase in other variable personnel costs, and a minor net increase in engineering and licensing personnel, non-cash stock compensation charges and state related gross receipts taxes incurred on certain licensing revenues recognized during the three months ended September 30, 2010.
|
|
◦
|
Patent amortization increased to
$2.0 million
, compared to
$1.2 million
, due primarily to the acceleration of patent amortization related to recoupable up-front patent portfolio acquisition costs that were recovered during the three months ended September 30, 2010 pursuant to the provisions of the underlying inventor agreements.
|
|
•
|
Revenues increased by
$71.2 million
, or
150%
, due primarily to an increase in the average revenue per executed agreement executed and
an increase in the number of agreements executed.
|
|
•
|
Cost of Revenues and Other Operating Expenses:
|
|
◦
|
Inventor royalties, net income attributable to noncontrolling interests, and contingent legal fees, on a combined basis, increased
64%
, primarily reflecting the increase in related revenues for the nine months ended
September 30, 2010
. The increase was less than the percentage increase in related revenues due to, in the aggregate, lower or no inventor royalty or contingent legal fee arrangement obligations associated with the
|
|
◦
|
Litigation and licensing expenses-patents increased to
$11.0 million
, as compared to
$8.4 million
, due to an increase in expenses incurred in connection with certain of our licensing and enforcement programs that went to trial and concluded, or were scheduled to go to trial in 2010 and settled as of the end of third quarter of 2010, our continued investment in ongoing licensing and enforcement programs, and a net increase in costs related to new licensing and enforcement programs commenced since the end of the prior year period. The increase was partially offset by a decrease in expenses related to certain of our enforcement programs that went to trial and/or otherwise concluded in 2009 or early 2010.
|
|
◦
|
Marketing, general and administrative expenses increased to
$18.7 million
, as compared to
$15.8 million
, primarily due to
an increase in variable performance-based compensation costs, an increase in other variable personnel costs, and a minor net increase in engineering and licensing personnel expenses and state related gross receipts taxes incurred on certain licensing revenues recognized in the third quarter of 2010.
|
|
◦
|
Patent amortization increased to
$5.5 million
, compared to
$3.4 million
, due primarily to scheduled amortization on patent portfolios acquired since the end of the prior year quarter and the acceleration of patent amortization related to recoupable up-front patent acquisition costs as described above.
|
|
•
|
Increases in patent-related legal expenses, including, but not limited to, increases in costs billed by outside legal counsel for discovery, depositions, economic analyses, damages assessments, expert witnesses and other consultants, case-related audio/video presentations and other litigation support and administrative costs, could increase our operating costs and decrease our revenue generating opportunities;
|
|
•
|
Our patented technologies and enforcement actions are complex, and, as a result, we may be required to appeal adverse decisions by trial courts in order to successfully enforce our patents;
|
|
•
|
New legislation, regulations or rules related to enforcement actions could significantly increase our operating costs and decrease our revenue generating opportunities; and
|
|
•
|
Courts may rule that our subsidiaries have violated certain statutory, regulatory, federal, local or governing rules or standards by pursuing such enforcement actions, which may expose us and our operating subsidiaries to material liabilities, which could harm our operating results and our financial position.
|
|
•
|
Online Promotion.
This patented technology generally relates to online promotion of consumer products and can be used to provide consumers with web access to discount coupons and rebate offers.
|
|
•
|
Shape Memory Alloys
. The patented technology generally relates to using shape memory alloys such as Nitinol to fabricate medical devices that utilize the memory effect and/or superelasticity of the alloy. The technology can be used to improve cardiovascular and endoscopic procedures such as embolic protection (inferior vena cava filters, carotid filters, etc.) and kidney stone retrieval.
|
|
•
|
Intraluminal Device
. This patented technology generally relates to securing intraluminal devices, such as stent grafts, in the body.
|
|
•
|
Information Portal Software.
The patented technology generally relates to customizable user interfaces presenting information from a variety of sources and can be used in public, private enterprise, and consumer portals.
|
|
•
|
Line Screen Printing
. This patented technology generally relates to line screen printing methods to produce halftone images. This technology can be used to facilitate prints that reduce artifacts such as color Moire.
|
|
•
|
Catheter Insertion.
The patented technology generally relates to catheterization of patients using a guide wire and a flushing port. The technology can be used to facilitate insertion of catheters for intravenous treatments such as chemotherapy for cancer, drug therapy for pain mitigation or antibiotic therapy for infections.
|
|
•
|
Portable Credit Card Processing.
This patented technology generally relates to delivering an order to a residence and validating credit card information using a portable device.
|
|
•
|
Disk Array Systems & Storage Area Network.
The patented technologies generally relate to Storage Area Network (SAN), covering various aspects of network-based storage devices, including architecture, data storage and monitoring, and disk array systems, covering disk drive interface, storage data integrity and system architecture.
|
|
•
|
Business Process Modeling (BPM)
. The patented technology generally relates to systems which define and execute business processes.
|
|
•
|
Wireless and Communications.
The patents cover various wireless and other communications technologies which can be used in cellular phone systems and optical networking products. The patents also cover inventions relating to database middleware, software development utilities, encryption and other technologies.
|
|
•
|
Wireless Multimedia.
This patented technology generally relates to retrieval of multimedia information by wireless devices. This technology can be used for relaying multimedia information such as real-time sporting events to handheld wireless devices.
|
|
•
|
Camera Support.
This patented technology generally relates to an apparatus for supporting cameras and can be used to mount Web cameras to structures such as monitors and laptops.
|
|
•
|
Lighting Control.
This patented technology generally relates to energy saving and control features of residential and commercial electrical lighting circuits and switches.
|
|
•
|
Greeting Card.
This patented technology generally relates to the processing and printing of greeting cards and can be used by online merchants.
|
|
•
|
Evaluation of Diamonds and Gemstones.
This patented technology uses computer models to generate faster and more accurate diamond and gemstone grading.
|
|
•
|
Optical Recording.
This patented technology generally relates to optical data storage devices and optical recording media, such as CDs, DVDs and Blu-ray Discs.
|
|
•
|
Mobile Computer.
The patent portfolio includes patents relating to improvements in user interfaces and the technologies used to create them. These technologies are in mobile devices such as mobile phones and tablet computers.
|
|
•
|
Computer Storage Restoration.
This patented technology generally relates to the restoration of storage devices to a previous state.
|
|
•
|
Video and Software.
The patented technologies generally relate to the encoding of video and tracking of video objects as well as software covering operating systems and object-oriented development environments.
|
|
•
|
Handheld Device
. This patented technology generally relates to capturing information from a source and providing items based on such information.
|
|
•
|
GPS.
This patented technology generally relates to interference identification and mitigation in GPS receivers, such as those found in various mobile devices (e.g., mobile phones, personal navigation devices, etc.) and other consumer and commercial applications.
|
|
•
|
Energy Trading.
This patented technology generally relates to the trading of electric energy between participants, such as utility companies.
|
|
•
|
MEMS.
The patented technologies generally relate to microelectromechanical systems known as MEMS and can be found in devices such as pressure sensors used in automotive, medical and industrial applications.
|
|
•
|
Automated Communications.
This patented technology generally relates to automating network transactions and can be used to control transactions, such as eCommerce, software updates, and data transfer.
|
|
•
|
Automatic Image Labeling.
This patented technology generally relates to the automatic labeling of digital images. It can be used to automatically generate and increment labels on images such as CAD drawings and maps.
|
|
•
|
Targeted Content Delivery.
This technology can be used to ascertain infrastructure related information about a client system, such as installed hardware or applications, as well as location, in order to send appropriate content to the client system.
|
|
|
Three Months Ended September 30,
|
|
Nine Months Ended September 30,
|
||||||||||||
|
|
2010
|
|
2009
|
|
2010
|
|
2009
|
||||||||
|
|
|
|
|
|
|
|
|
||||||||
|
Revenues
|
$
|
63,949
|
|
|
$
|
16,169
|
|
|
$
|
118,727
|
|
|
$
|
47,482
|
|
|
|
Three Months Ended September 30,
|
|
Nine Months Ended September 30,
|
||||||||
|
|
2010
|
|
2009
|
|
2010
|
|
2009
|
||||
|
|
|
|
|
|
|
|
|
||||
|
New agreements executed
|
51
|
|
|
36
|
|
|
180
|
|
|
85
|
|
|
Licensing and enforcement programs with initial revenues
|
12
|
|
|
3
|
|
|
27
|
|
|
8
|
|
|
•
|
the dollar amount of agreements executed each period, which can be driven by the nature and characteristics of the technology or technologies being licensed and the magnitude of infringement associated with a specific licensee;
|
|
•
|
the specific terms and conditions of agreements executed each period, including the nature and characteristics of rights granted, and the periods of infringement or term of use contemplated by the respective payments;
|
|
•
|
fluctuations in the total number of agreements executed;
|
|
•
|
fluctuations in the sales results or other royalty per unit activities of our licensees that impact the calculation of fees due;
|
|
•
|
the timing of the receipt of periodic payments and/or reports from licensees; and
|
|
•
|
fluctuations in the net number of active licensees period to period.
|
|
|
Three Months Ended September 30,
|
|
Nine Months Ended September 30,
|
||||||||||||
|
|
2010
|
|
2009
|
|
2010
|
|
2009
|
||||||||
|
|
|
|
|
|
|
|
|
||||||||
|
Cost of revenues:
|
|
|
|
|
|
|
|
||||||||
|
Inventor royalties
|
$
|
14,508
|
|
|
$
|
4,673
|
|
|
$
|
21,296
|
|
|
$
|
12,069
|
|
|
Contingent legal fees
|
9,739
|
|
|
3,799
|
|
|
17,611
|
|
|
10,521
|
|
||||
|
Litigation and licensing expenses - patents
|
2,890
|
|
|
3,957
|
|
|
11,019
|
|
|
8,418
|
|
||||
|
Amortization of patents
|
1,963
|
|
|
1,245
|
|
|
5,542
|
|
|
3,370
|
|
||||
|
Net income attributable to noncontrolling interests in operating subsidiary
|
3,107
|
|
|
1,029
|
|
|
3,389
|
|
|
3,150
|
|
||||
|
|
Three Months Ended September 30,
|
|
Nine Months Ended September 30,
|
||||
|
|
2010 vs. 2009
|
|
2010 vs. 2009
|
||||
|
|
|
|
|
|
|
||
|
Increase in revenues
|
296
|
%
|
|
|
150
|
%
|
|
|
Increase in inventor royalties and net income attributable to noncontrolling interests
|
209
|
%
|
Note (a)
|
|
62
|
%
|
Note (a)
|
|
Increase in contingent legal fees expense
|
156
|
%
|
Note (b)
|
|
67
|
%
|
Note (b)
|
|
Increase in inventor royalties expense, net income attributable to noncontrolling interests and contingent legal fees expense
|
188
|
%
|
Note (a),(b)
|
|
64
|
%
|
Note (a),(b)
|
|
|
Three Months Ended September 30,
|
|
Nine Months Ended September 30,
|
||||||||||
|
|
2010
|
|
2009
|
|
|
2010
|
|
2009
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
||||
|
Inventor royalties and net income attributable to noncontrolling interests as a percentage of revenues
|
28
|
%
|
|
35
|
%
|
Note (a)
|
|
21
|
%
|
|
32
|
%
|
Note (a)
|
|
Contingent legal fees expense as a percentage of revenues
|
15
|
%
|
|
23
|
%
|
Note (b)
|
|
15
|
%
|
|
22
|
%
|
Note (b)
|
|
Inventor royalties, net income attributable to noncontrolling interests and contingent legal fees, combined, as a percentage of revenues
|
43
|
%
|
|
59
|
%
|
Note (a),(b)
|
|
36
|
%
|
|
54
|
%
|
Note (a),(b)
|
|
(a)
|
The increase in inventor royalties and net income attributable to noncontrolling interests was less than the increase in revenues for the periods presented, primarily due to a portion of revenues recognized during the periods ended
September 30, 2010
having no corresponding inventor royalty arrangement obligations, and in the aggregate, lower inventor royalty rates associated with the portfolios generating revenues during the periods ended
September 30, 2010
, as compared to the prior year periods.
|
|
(b)
|
The increase in contingent legal fees expense was less than the increase in revenues for the periods presented, primarily due to a portion of revenues recognized during the periods ended
September 30, 2010
having no corresponding contingent legal fee arrangement obligations, and in the aggregate, lower contingent legal fee rates associated with the portfolios generating revenues during the periods ended
September 30, 2010
, as compared to the prior year periods.
|
|
|
Three Months Ended September 30,
|
|
Nine Months Ended September 30,
|
||||||||||||
|
|
2010
|
|
2009
|
|
2010
|
|
2009
|
||||||||
|
|
|
|
|
|
|
|
|
||||||||
|
Marketing, general and administrative expenses (including non-cash stock compensation expense of $1,615 and $5,574 for the three and nine months ended September 30, 2010, respectively and $1,472 and $5,573 for the three and nine months ended September 30, 2009, respectively)
|
$
|
6,353
|
|
|
$
|
4,709
|
|
|
$
|
18,741
|
|
|
$
|
15,835
|
|
|
|
Three Months
|
|
Nine Months
|
||||
|
|
Ended September 30,
|
|
Ended September 30,
|
||||
|
|
2010 vs. 2009
|
|
2010 vs. 2009
|
||||
|
|
|
|
|
||||
|
Addition of licensing, business development and engineering personnel and other personnel costs
|
$
|
280
|
|
|
$
|
720
|
|
|
Increase in variable performance-based compensation and other variable personnel costs
|
989
|
|
|
1,715
|
|
||
|
Corporate, general and administrative costs
|
66
|
|
|
308
|
|
||
|
State and foreign gross receipts taxes
|
166
|
|
|
162
|
|
||
|
Non-cash stock compensation expense
|
143
|
|
|
1
|
|
||
|
|
Three Months Ended September 30,
|
|
Nine Months Ended September 30,
|
||||||||||||
|
|
2010
|
|
2009
|
|
2010
|
|
2009
|
||||||||
|
|
|
|
|
|
|
|
|
||||||||
|
Provision for income taxes
|
$
|
(297
|
)
|
|
$
|
(47
|
)
|
|
$
|
(605
|
)
|
|
$
|
(124
|
)
|
|
Effective tax rate
|
1.06
|
%
|
|
(2.00
|
)%
|
|
1.40
|
%
|
|
(3.71
|
)%
|
||||
|
|
Nine Months Ended
|
||||||
|
|
September 30, 2010
|
|
September 30, 2009
|
||||
|
|
|
|
|
||||
|
Net cash provided by (used in):
|
|
|
|
||||
|
Operating activities
|
$
|
30,347
|
|
|
$
|
5,896
|
|
|
Investing activities
|
(3,113
|
)
|
|
(8,232
|
)
|
||
|
Financing activities
|
4,457
|
|
|
(3,143
|
)
|
||
|
|
Payments Due by Period (In thousands)
|
||||||||||||||||||
|
Contractual Obligations
|
Total
|
|
Less than 1 year
|
|
1-3 years
|
|
3-5 years
|
|
More than 5 years
|
||||||||||
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Operating leases
|
$
|
1,620
|
|
|
$
|
187
|
|
|
$
|
1,433
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
Total contractual obligations
|
$
|
1,620
|
|
|
$
|
187
|
|
|
$
|
1,433
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
31.1
|
Certification of Chief Executive Officer Pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934
|
|
31.2
|
Certification of Chief Financial Officer Pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934
|
|
32.1
|
Certification of Chief Executive Officer Pursuant to Rule 13a-14(b)/15d-14(b) of the Securities Exchange Act of 1934 and 18 U.S.C. Section 1350
|
|
32.2
|
Certification of Chief Financial Officer Pursuant to Rule 13a-14(b)/15d-14(b) of the Securities Exchange Act of 1934 and 18 U.S.C. Section 1350
|
|
|
ACACIA RESEARCH CORPORATION
|
|
|
|
|
|
|
|
By: /
s/ Paul R. Ryan
|
|
|
|
Paul R. Ryan
|
|
|
|
Chief Executive Officer
|
|
|
|
|
|
|
|
By: /s/ Clayton J. Haynes
|
|
|
|
Clayton J. Haynes
|
|
|
|
Chief Financial Officer and Treasurer
|
|
|
EXHIBIT
NUMBER
|
EXHIBIT
|
|
|
|
|
31.1
|
Certification of Chief Executive Officer Pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934
|
|
31.2
|
Certification of Chief Financial Officer Pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934
|
|
32.1
|
Certification of Chief Executive Officer Pursuant to Rule 13a-14(b)/15d-14(b) of the Securities Exchange Act of 1934 and 18 U.S.C. Section 1350
|
|
32.2
|
Certification of Chief Financial Officer Pursuant to Rule 13a-14(b)/15d-14(b) of the Securities Exchange Act of 1934 and 18 U.S.C. Section 1350
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|